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Abstract.  We have investigated the nature and distri- 
bution of different populations of heparan  sulfate pro- 
teoglycans (HSPGs) in several cell lines in culture. 
Clone 9 hepatocytes and NRK and CHO cells were 
biosynthetically labeled with 35SO4, and proteoglycans 
were isolated by DEAE-Sephacel chromatography. 
Heterogeneous populations of HSPGs and chondroi- 
tin/dermatan  proteoglycans (CSPGs) were found in the 
media and cell layer extracts of all cultures.  HSPGs 
were further purified from the media and cell layers 
and separated from CSPGs by ion exchange chroma- 
tography after chondroitinase ABC digestion.  In all 
cell types, HSPGs were found both in the cell layers 
(20-70%  of the total) as well as the medium.  When 
the purified HSPG fractions were further separated by 
octyl-Sepharose chromatography,  very little HSPG in 
the incubation media bound to the octyl-Sepharose, 
whereas 40-55 % of that in the cell layers bound and 
could be eluted with  1% Triton X-100. This hydropho- 
bic population most likely consists of membrane- 
intercalated HSPGs. Basement membrane-type HSPGs 
were identified by immunoprecipitation as a compo- 
nent (30-80%) of the unbound (nonhydrophobic) 
HSPG fraction.  By immunofluorescence, basement 
membrane-type HSPGs were distributed in a reticular 
network in Clone 9 and NRK cell monolayers; by im- 
munoelectron microscopy, these HSPGs were localized 
to irregular clumps of extracellular matrix located be- 
neath and between cells. The cells did not produce a 
morphologically recognizable basement membrane 
layer under these culture conditions.  When membrane- 
associated HSPGs were localized by immunoelectron 
microscopy, they were found in a continuous layer 
along the cell membrane of all cell types. 
The results demonstrate that (a) two antigenicaUy 
distinct populations of HSPG-an extracellular matrix 
and a membrane-intercalated  population-are  found at 
the surface of several different cultured cells lines;  (b) 
these populations can be distinguished from one an- 
other by differences in their distribution in the 
monolayers by immunocytochemistry and can be sepa- 
rated by hydrophobic chromatography;  and (c) base- 
ment membrane-type HSPGs are secreted and depos- 
ited in the extracellular matrix by cultured cells even 
though they do not produce a bona fide basement 
membrane-like layer. 
H 
EPARAN sulfate proteoglycans  (HSPGs)  ~  of different 
molecular sizes and structures have been found at the 
surfaces of many different types of cells in tissues 
and in cultures (12). We have previously reported that two 
antigenically  distinct  populations of HSPG can be distin- 
guished in a number of tissues based on their localization 
with specific antibodies:  one type was associated exclusively 
with basement membranes (7, 24, 35, 37) and the other with 
the plasma membranes (7, 35, 36) of liver and kidney cells. 
To determine whether or not similar populations of HSPGs 
are made by cultured cells,  we have (a) analyzed HSPGs 
made by hepatocyte  (Clone 9),  normal rat kidney (NRK), 
1. Abbreviations  used in this paper:  CSPG, chondroitin/dermatan sulfate 
proteoglycan;  DAB, diaminobenzidine; GBM, glomerular basement mem- 
brane; GuHCI,  guanidine hydrochloride;  HRP, horseradish peroxidase; 
HSPG,  heparan sulfate proteoglycan;  LM, liver microsomes. 
and Chinese hamster ovary (CHO) cell lines;  (b) partially 
characterized  these HSPGs by ion-exchange  and hydropho- 
bic chromatography;  and (c) determined their distribution by 
immunochemical  and immunocytochemical  procedures. 
Materials and Methods 
Materials 
Guanidine hydrochioride  (GuHCI),  3-[(3-cholamidopropyl)dimethyl-am- 
monio]-l-propane sulfonate  (CHAPS),  diaminobenzidine (DAB)  hydro- 
chloride, type II, phenylmethylsulfonyl  fluoride (PMSF), benzamidine hy- 
drochloride, 6-aminohexanoic  acid,  and Protein A-Sepharose 4B beads 
were obtained from Sigma Chemical Co. (St. Louis, MO). Na35[SO4] (car- 
rier free) was obtained from ICN (Chemical and Radioisotope  Division, 
Irvine, CA). Chondroitinase ABC and heparifinase were from Miles Scien- 
tific Div. (Naperville, IL), and chromatographic resins were from Pharma- 
cia Fine Chemicals (Piscataway, N J). 
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Figure  1.  Ion exchange chromatography of 35SO4-1abeled  extracts 
obtained from cultures of Clone 9  (A), NRK (B), and CHO (C) 
cells.  Cultures were labeled for 24 h  with 35SO4, extracted with 
4  M  GuHCI, exchanged into 8 M  urea buffer, applied to DEAE- 
Sephacel columns and eluted with a continuous NaC1 gradient. In 
all cases, the proteoglycans extracted from the cell layers (0) and 
the media  (*)  consisted  of broad peaks  (indicated by the bars) 
which eluted at 0.4-1.0 M  NaC1. 
Fraction 
Figure 2.  Ion exchange chromatography of chondroitinase ABC- 
digested,  3sso4-1abeled  proteoglycans  obtained  from  the  media 
(.)  and cell layers (o) of Clone 9  (A),  NRK (B), and CHO (C) 
cells.  Proteoglycan peaks  eluted  from DEAE-Sephacel  columns 
(see Fig. 1) were concentrated, digested for 3 h at 45°C with chow 
droitinase ABC, and rechromatographed on DEAE-Sephacel. The 
digested CSPG fragments elute as one or two early peaks at low salt 
concentrations which could be clearly separated from the HSPG 
peak eluting at 0.4 M  NaCI (indicated by the bars). 
Antibodies 
Polyclonal  serum was prepared against purified glomerular proteoglycans 
and was shown to specifically recognize the core protein of the population 
of HSPGs (Mr 130000)  found in the rat glomerular basement membrane 
(GBM) by immunopreeipitation (37). By immunocytochemistry  this anti- 
body, referred to as anti-HSPG (GBM), stains basement membranes in the 
kidney and in other tissues.  Polyclonal serum raised against HSPG purified 
from rat liver microsomes (LM) was kindly provided by Dr. Magnus H66k 
(University of Alabama). This antibody,  referred  to as anti-HSPG (LM) 
was  previously  shown to  specifically  recognize the core protein of the 
heparin-releasable and membrane-intercalated forms of membrane-associ- 
ated HSPG (36) by immunoprecipitation.  By immunocytochemistry  it stains 
the basolateral  or vascular domain of hepatocytes  (36).  Fab fragments  of 
sheep anti-rabbit IgG conjugated  to horseradish peroxidase  (HRP) were 
from Biosys (Compi~gne,  France), and rhodamine-conjugated  goat anti- 
rabbit IgG was from Cooper Biomedical  Inc.  (Malvern, PA). 
Cell Culture 
A rat hepatocyte cell line (Clone 9) was obtained from Dr. David Sabatini 
(New York University). Normal rat kidney (NRK) cells were provided by 
Dr.  Soni Anderson (1)  and were  originally obtained from  Dr.  George 
Todaro, Oncogene (Seattle, WA). Chinese hamster ovary (CHO) cells were 
from the American Type Culture Collection (Rockville,  MD). Cells were 
grown in MEM or in F12 nutrient mixture (Gibco, Grand Island, NY) sup- 
plemented with 10% FCS in an atmosphere of 95% air, 5% CO2, and were 
passaged  weeldy. For immunocytochemical  experiments  they were plated 
onto 35-ram plastic dishes and grown to contIuency, and for biosynthetic 
labeling experiments  they were grown in 25-cm  2 flasks. 
Biosynthetic  Labeling  of  Proteoglycans 
Confluent cultures were incubated for 24 h in 2 ml of MEM containing 5 % 
FCS and 35SO4 (200 pCi/ml). After labeling, the medium was collected 
and centrifuged (2,000  rpm,  10 min) to remove cell debris, tx~a volumes 
of 6 M GuHC1, 0.075 M sodium acetate, 0.75% CHAPS,  and 1 gM PMSF 
were added, and the medium was stored at -20°C. 2 ml of ice cold, 4 M 
GuHC1 (containing 0.5% CHAPS, 50 mM sodium EDTA, 5 mM benzami- 
dine HCI, 0.1 M 6-aminohexanoic  acid, 1 ttM PMSF, and 50 mM sodium 
acetate, pH 6.0) were added to the cell layer, and the cells were scraped off 
the dish and extracted in suspension for 16 h at 4°C with constant shaking. 
Unextracted  residues were removed  by centrifugation (13,000 rpm for 10 
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Figure 3. Octyl-Sepharose chromatography of HSPG fractions ob- 
tained as shown in Fig. 2  from Clone 9  (A), NRK (B), and CHO 
(C)  cell  layers.  35SO4-HSPGs  were  incubated with octyl-Sepha- 
rose resin in the presence of 0.4% cholate and eluted step-wise with 
3 M  NaC1 and 1% Triton X-100 at the points indicated. The peaks 
eluted with Triton Xd00 represent the most hydrophohic popula- 
tions of HSPG. 
rain), and the supernatants were stored at -20°C. This extraction procedure 
35  solubilizes 90-95 % of the  S04-1abeled  proteoglycans from the cell layer. 
Isolation of  Proteoglycans 
Unincorporated 3sSO4, GuHCI,  and other salts were removed from the 
medium and cell extracts by chromatography on Sephadex G-50  (fine) 
columns (0.5  x  16 cm) equilibrated and eluted with 8 M urea, 0.15 M NaC1, 
0.05 M sodium acetate, pH 6.0 (Buffer A). The excluded fractions were then 
applied to a column of DEAE-Sephacel (5-ml bed volume) preequilibrated 
in Buffer A  with 0.5%  (wt/vol) CHAPS.  After sample application, the 
columns were washed with ,x,5 ml of the same buffer and then eluted with 
a continuous NaCI gradient (0.15-1.5 M) in Buffer A using a total of 46 ml 
(40). Fractions (~1 nil) wore collected at a flow rate of 'x,3 ml/h, and ali- 
quots were counted for radioactivity. 
Fractions containing the 35SO4-1abeled proteoglycans which elnted as a 
single, broad peak (see Fig. 1) were pooled and concentrated for use in the 
assays described below by diluting the pooled sample with 8 M urea to give 
a final concentration of <0.2 M NaC1.  The sample was then reapplied to 
a DEAE-Sephacel column (200-I.tl bed volume) and eluted with 100-gl ali- 
quots of 1 M NaCI in Buffer A. Recovery of radiolabeled proteoglycans was 
consistently •90%. 
Enzymatic Treatments 
Proteoglycan fractions were digested either with chondroitinase ABC (0.05 
U/ml) in 50 mM Tris-HCl, pH 7, with 1 IxM PMSF for 3 h at 45°C (33) 
or with heparitinase (0.1 U/ml) in 50 mM Tris-HC1,  10 mM calcium ace- 
tare,  pH 7, containing 1 ~M PMSF for 3 h at 370C (20). 
Chromatography on Sepharose CL-6B 
The relative proportion of heparan sulfate and chondroitin/dermatan sulfate 
proteoglycan (CSPG) in each extract was determined by Sepharose CL-6B 
chromatography  before  and  after  digestion  with  heparitinase  or  chon- 
droitinase ABC.  Sepharose CL-6B columns (0.7  x  100 cm) were equili- 
brated with 4 M GuHCI, 0.05 M Tris-HCl, 0.05 M sodiumsulfate, 0.5% 
Triton X-100, pH 7.0. Fractions (0.6 ml) were collected, and aliquots were 
counted for radioactivity. 
Isolation of  HSPGs 
35SO4-Labeled proteoglyean fractions that had been digested with chon- 
droitinase ABC were diluted in Buffer A, reapplied to a DEAE-Sephacel 
column (2-ml bed volume), and eluted with a continuous NaCI gradient as 
described  above.  Chondroitin  sulfate  disaccharides  eluted  at  low  salt 
concentrations and  were discarded.  The  remaining 35SO4 radioactivity, 
representing intact HSPG, was collected and used for octyl-Sepharose chro- 
matography. 
Separation of  HSPG by Hydrophobic Chromatography 
Purified 35SO4-HSPGs  (",,5-30  ml)  were  reapplied to  DEAE-Sephacel 
columns (1 ml resin), and the bound HSPGs were washed with 20 ml 2% 
sodium cholate in 0.15 M  NaCI,  20 mM Tris-HCl, pH 7.3,  followed by 
10 ml 0.4% cholate in the same buffer and then eluted with 0.4% cholate 
in 1 M  NaCI, 20 mM Tris-HCI, pH 7.3. Fractions were diluted to 0.4% 
cholate, 0.6 M NaC1, 20 mM Tris, pH 7.3, and applied to an octyl-Sepharose 
column (2 rnl resin); the column was incubated overnight at 4°C and then 
elnted sequentially with 10 ml of each of the following: (a) 0.15 M NaCI; 
(b) 3 M NaCl; and (c) 1% Triton X-100, 3 M NaCI, all in 20 mM Tris-HCl, 
pH 7.3 (31).  1-ml fractions were collected and counted for radioactivity. 
Immunoprecipitation 
Anti-HSPG (GBM) was bound to Protein A-Sepharose beads by incubating 
the washed beads in anti-HSPG serum (diluted 1:1 in PBS) for 1 h at 20°C. 
The beads were collected and washed twice in PBS and twice in RIPA buffer 
(5) (0.15 M NaCI, 100 mM Tris-HC1, pH 7.4, 1% Triton X-100, 0.1% deoxy- 
cholate, 0.1%  SDS,  10 mM EDTA). 
Isolated HSPG fractions (see Fig. 2) and subfractions elnted from the 
octyl-Sepharose column (see Fig. 3) were purified and concentrated over 
DEAE-Sephacel columns as described above.  The  fractions were then 
diluted to a volume of 1.5 ml in RIPA buffer containing 4 ~tl of normal rabbit 
serum, and after a  15-rain incubation at 20°C, 40 gl Protein A-Sepharose 
was added and the samples were centrifuged (13,000 rpm for 2 min). The 
supernatant was mixed with 40 gl of Protein A-Sepharose beads with bound 
anti-HSPG (GBM) and incubated for 3 h at 20°C or 4°C overnight on a Nu- 
tator. The beads were washed three times in RIPA buffer, once in PBS, solu- 
bilized directly in scintillation fluid, and the amount of bound radioactivity 
was determined. 
lmmunofluorescence 
Cultures grown on 35-ram petri dishes were prepared for immunofluores- 
cence by one of two methods. Monolayers were either (a) fixed in formalin 
for 10 rain and then permeabilized with 0.2% Triton X-100 in PBS for 10 
rain, or (b) they were treated with 2 % Triton X-100 in PBS to extract the 
cells, and the matrix material remaining attached to the dishes was fixed in 
formalin. The cells and/or matrices were then reacted in the dishes sequen- 
tially with anti-HSPG (GBM) serum for 1 h, followed by goat anti-rabbit IgG 
conjugated to rhodamine, after which they were coverslipped and viewed 
in a Zeiss Photomicroscope III by epifluorescence illumination. 
Immunoperoxidase Staining 
Fixation and incubations were carried out as detailed previously (3).  In 
brief, cells grown in 35-raM culture dishes were fixed for 3 h at 20°C by 
Stow and Farquhar Heparan Sulfate Proteoglycans in Cultured Cells  531 Table L Percent HSPG and CSPG Found in the Media and Cell Layers of Cell Lines* 
Clone 9  NRK  CHO 
Cell types  Cell layer  Medium  Cell  layer  Medium  Cell  layer  Medium 
Total 3sSO4  585,400  992,110  620,000  750,000  712,000  804,540 
Proteoglycan 
(cpm per dish) n  =  6 
%  HSPG  35  20  51  50  60  70 
%  CSPG  65  80  49  48  45  40 
* Cultures  were labeled for 24 h with 200 I~Ci/ml 3~SO4. The media and cell layers were extracted  in 4 M GuHCI and 0.5% CHAPS and chromatographed  over 
Sephadex G50 and DEAE-Sephacel columns as described in Materials  and Methods. The total amount of 3sSO4-1abeled proteoglycans  in each extract was deter- 
mined by counting the proteoglycan  peak recovered off the DEAE-Sephacol column. The percentages of HSPG and CSPG were determined by counting  the 
35SO4 radioactivity  recovered in the proteoglycan  peak by Sepharose CL6B chromatography  before and after digestion of proteoglycans  with chondroitinase  ABC 
or heparitinase,  respectively,  as described in Materials  and Methods. 
replacing the growth medium with the fixative of McLean and Nakane (22) 
(2% paraformaldehyde, 0.75%  lysine, 10 mM NaIO4 in 35 mM phosphate 
buffer, pH 6.2). They were then (a) incubated in either anti-HSPG (GBM) 
(1/50), anti-HSPG (LM) (1/10), or normal rabbit (1/50) serum (in PBS); (b) 
incubated in F(ab) fragments of sheep anti-rabbit IgG conjugated to HRP 
(2 h);  (c) fixed in  1.5%  glutaraldehyde (1 h);  (d) reacted with DAB and 
H202,  followed by (e) postfixation in ferrocyanide-reduced OsO4, and (f) 
dehydration and embedding in epoxy resin for electron microscopy. In some 
experiments, cells were scraped off the dish before postfixation-in OsO4, 
pelleted (in a Microfuge) and processed and embedded as pellets. In others 
the cell layers were processed in the dishes up to the propylene oxide step 
(when they detached) after which they were oriented during embedding so 
that the monolayers could be sectioned either vertically (top to bottom) or 
enface. Ultrathin sections were stained with lead citrate and photographed 
in a Philips 301 electron microscope. 
Results 
Characterization  of  Proteoglycans in the Culture 
Medium and Cell Layer 
When Clone 9, NRK, and CHO cell cultures were labeled 
for 24 h  with 35SO4 and the extracted proteoglycans were 
analyzed by DEAE-Sephacel chromatography, the medium 
and cell extracts of all cell lines were found to contain hetero- 
geneous populations of 35SO4-1abeled proteoglycans which 
eluted as broad peaks between 0.4-1.0  M  NaC1 (Fig.  1). 
Small peaks  of 35SO4 radioactivity, consisting of sulfated 
glycoproteins, eluted at low salt concentrations (0.1-0.3 M) 
(40) and were not analyzed further. 
To determine the type of proteoglycans present, the pro- 
teoglycan fractions eluted from DEAE-Sephacel columns 
were analyzed by molecular sieve chromatography on Sepha- 
rose CL-6B columns before and after digestion with either 
chondroitinase ABC or heparitinase.  The undigested pro- 
teoglycan fractions from all cell layer and medium extracts 
eluted from CL-6B columns as very broad peaks (not shown), 
indicating that the proteoglycans present are heterogenous in 
size.  The percent of the total proteoglycans constituted by 
HSPG and CSPG is shown in Table I. HSPGs, identified by 
their susceptibility to digestion with heparitinase and not 
chondroitinase ABC,  accounted  for 20-50%  of the  total 
35SO4-1abeled proteoglycans found in both the medium and 
cell extracts of Clone 9 and NRK cells and 60-70 % of those 
made by CHO cells. The remaining proteoglycans were sus- 
ceptible to chondroitinase ABC and thus consisted of CSPG. 
When the 35SO4-1abeled proteoglycan fractions which had 
been  treated with chondroitinase ABC  were  rechromato- 
graphed on DEAE-Sephacel (Fig. 2), purified HSPGs (which 
eluted at 0.5-0.9  M  NaCI)  could be  separated  from the 
digested CSPGs (which eluted earlier) and subjected  to fur- 
ther analysis. 
Separation of  HSPG by Hydrophobic  Chromatography 
Proteoglycans of varying hydrophobicity can be separated by 
binding  to  octyl-Sepharose  followed  by  their  selective 
elution with detergent (16, 25,  31). When purified 35504- 
labeled HSPGs obtained from GuHC1 extracts of the medium 
and cell layers were  separated according to their affinity 
for octyl-Sepharose, relatively little HSPG (~20%)  in the 
medium obtained from any cell type bound to the column 
(Table II). However,  a significant fraction (40-55 %) of the 
HSPGs obtained from each of the cell layers did bind and was 
eluted with 1% Triton X-100 (Fig.  3, Table II).  The HSPGs 
that bound and could be eluted with  1%  Triton X-100 are 
assumed  to  represent  membrane-intercalated  HSPGs,  and 
the unbound HSPGs are assumed to consist of other forms- 
i.e., not  membrane-intercalated.  These  data  suggest  that 
among the HSPGs produced by all three cell types, a large 
proportion consists  of HSPGs with core proteins  containing 
more hydrophobic regions, presumably membrane-anchor- 
ing domains (16). 
Immunoprecipitation of  Basement Membrane HSPGs 
The 35SO4-1abeled HSPG fractions prepared by hydropho- 
bic chromatography were tested for their reactivity with an- 
Table II.  Separation of Purified HSPG by Hydrophobic Chromatography* 
Clone 9  NRK  CHO 
Cell Line  Cell layer  Medium  Cell layer  Medium  Cell layer  Medium 
%  HSPG bound  40  15  40  9  55  18 
*35SO4-1abeled HSPG were isolated by chondroitinase-ABC  digestion of the total proteoglycans, and the purified HSPG from each cell layer and medium extract 
was chromatographed  on octyl-Sepharose  columns eluted with Triton  X-100  as described in Materials  and Methods. These percentages reflect the total ~5SO4 
radioactivity  that bound to octyl-Sepharose  in samples from six labeling experiments. 
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proteins  in Clone 9 cell cultures  following extraction of the cell 
layer. Monolayers were treated with 2 % Triton X-100, and the mate- 
rial remaining in the dish was fixed in formalin and incubated with 
anti-HSPG (GBM) (A), anti-fibronectin (B), or anti-laminin  (C) 
followed by rhodamine-conjugated goat anti-rabbit IgG. All three 
antibodies stain an irregular network of extracellular material ad- 
hering to the culture flask. Bar, 100 I~m. 
ti-HSPG (GBM) or normal rabbit serum by immunoprecipi- 
tation. HSPGs could be precipitated with anti-HSPG (GBM) 
serum from the fractions which did not bind to octyl-Sepha- 
rose, whereas they could not be precipitated from the bound 
fraction.  The  amount of HSPG precipitated  from the  un- 
bound fractions obtained from the media and the cell layers 
varied considerably from cell type to cell type. The amount 
precipitated from the medium was very low in Clone 9 hepa- 
tocytes (2%) and NRK cells (7%), but was higher in CHO 
cells (22%).  The amount precipitated  from the cell layers 
was highest  in  Clone 9  (80%)  and  NRK cells  (60%)  and 
lowest (30%) in CHO cells. It can be concluded that (a) un- 
der  these  conditions  basement  membrane  HSPGs  do  not 
bind to octyl-Sepharose; (b) they can be separated from more 
hydrophobic populations of HSPG by octyl-Sepharose chro- 
matography;  and  (c)  the  amount  of  immunoprecipitated 
basement membrane HSPG present in  the  cell  layers and 
released into the medium varies among different cell types. 
We were unable to carry out similar immunoprecipitations 
with anti-HSPG (LM) serum due to an insufficient supply 
of the antibody. 
Distribution of  Basement Membrane HSPG 
in the Monolayers 
When Clone 9 cell monolayers were treated with 2 % Triton 
X-100 (to extract the cells), and the residues were fixed and 
stained with anti-HSPG (GBM) by immunofluorescence, a 
web-like, reticular array of extracellular matrix-like mate- 
rial was seen adhering to the dish (Fig. 4 A). A similar web- 
like matrix was seen after staining NRK cells, but none was 
seen in CHO cell cultures. When the Clone 9 cell residues 
were stained for fibronectin (Fig. 4 B) and laminin (Fig. 4 
C),  a  similar staining pattern was seen. 
When the monolayers of Clone 9 hepatocytes were fixed, 
incubated with anti-HSPG (GBM), and reacted by immuno- 
peroxidase  for electron  microscopy, clumps of DAB-con- 
taming extracellular material of varied sizes and shapes were 
seen adhering to the cell surface beneath and between cells 
(Fig. 5, A-E). These clumps are assumed to be cross sections 
through the web-like reticulum seen by immunofluorescence. 
Sometimes the stained extracellular material was located in 
deep pockets of the cell membrane whose connection to the 
cell surface was not always visible in the plane of the section 
(Fig. 5 B). In other cases, reaction product was concentrated 
in adhesion plaques located at the base of  the cells where they 
attach to the culture dish (Fig. 5 A). Since the cells were not 
permeabilized, no intracellular staining was seen.  Interest- 
ingly, there was no morphologically recognizable basement 
membrane-like layer layed down by this or any of the other 
cell types studied. 
when cultured NRK cells were similarly reacted by im- 
munoperoxidase, anti-HSPG (GBM)-reactive material was 
also  found  in  extracellular  locations  (Fig.  6,  A-C).  The 
stained material was typically distributed in smaller patches 
which  were  closely  adherent  to  the  cell  surface  beneath 
and between the cells. It was often associated with bundles 
of smaller wispy fibers projecting from the cell surface (Fig. 
6B). 
CHO cells possessed a relatively small amount of extracel- 
lular material that reacted with anti-HSPG (GBM) by im- 
munoperoxidase when compared to Clone 9 and NRK cells. 
The reactive material was restricted to smaller patches lo- 
cated at points of adherence between adjacent cells (Fig. 7, 
A and B), and little or none was deposited beneath the cells. 
It is concluded that (a) all three cell types studied produce 
basement membrane-type HSPG and deposit it extracellu- 
larly  in  irregular  clumps  of extracellular  matrix  material 
which are concentrated at sites of cell-cell or cell-substrate 
adhesion, and (b) these HSPGs are not incorporated into an 
organized basement membrane-like layer. 
Distribution of  Membrane-associated HSPG 
in the Monolayers 
When cultures of Clone 9 cells were reacted with anti-HSPG 
Stow and Farquhar  Heparan  Sulfate Proteoglycans  in Cultured  Cells  533 Figure 5. Distribution  of basement membrane HSPGs in Clone 9 hepatocytes as seen by immunoperoxidase  staining. Cells were incubated 
sequentially in anti-HSPG (GBM), sheep anti-rabbit  Fab conjugated to HRP, and DAB medium. Deposits of extracellular material of vari- 
able size and organization which react with the antibody are found along the cells' surfaces. In A, these HSPGs are seen to be associated 
with adhesion plaques (ad) located at the base of the cell where it makes contact with the plastic substratum (p) and in a large deposit 
(arrows) of extracellular material located in a pocket of the cell membrane (cm). Note that the plasmalemma itself (cm) is not reactive; 
however, there appears to be some staining of the adjacent cell membrane due to diffusion of reaction product from its site of generation 
in the matrix. These cells do not make a morphologically  recognizable basement membrane layer, nu, nucleus. B shows what is assumed 
to be a similar pocket containing reactive extracellular  matrix material whose continuity with the plasma membrane is not evident in the 
plane of the section.  C shows several such masses located in the intercellular spaces between the overlapping cell membranes (cm) of two 
adjacent cells (C1 and C2). Fibrillar strands  (fi) are seen adjacent to the upper deposit.  D and E demonstrate  aggregates of matrix-like 
material that stains for basement membrane proteoglycans (short arrows) sandwiched between the overlapping edges of adjacent ceils (C1 
and C2). These HSPGs are also detected in a mass of material  located near the junction between two cells (long arrow in D) and in a 
layer beneath the surface of another cell ((73 in E). Bars:  0.5 Itm. 
The Journal  of Cell Biology, Volume 105, 1987  534 Figure 6. Distribution  of basement membrane HSPGs in NRK ceils incubated with anti-HSPG (GBM) as in Fig. 5. (A) Section cut through 
a monolayer (top to bottom) of NRK cells.  Large clumps of stained material  (arrows) are found between the basal surface of the cells 
and the plastic  substratum  (p). In contrast to Clone 9 cells,  no clumps of extracellular  matrix are seen on the upper surface of these cells 
which faces the culture medium. (B) Grazing section of cells cut enface showing clumps of reactive  fibrillar  material  located  in pockets 
of the cell membrane between adjacent cells (arrows). (C) The fibrillar  extracellular  material  located  in very close association with the 
surfaces  of two adjacent cells  (C1 and C2) is shown here at higher magnification.  Bars: 0.5  Ilm. 
(LM) by the immunoperoxidase procedure,  the distribution 
of reaction product was quite different from that in speci- 
mens incubated with anti-HSPG (GBM): it was distributed 
in a continuous layer along the cell membrane (Fig. 8, A and 
B), and the extracellular material was not stained.  Reaction 
product was not restricted to specific domains of the cell sur- 
face but occurred as a  continuous layer outlining the entire 
exposed  surface  of the  cells.  It was also present  in  small 
vesicular profiles found in continuity with the cell membrane 
or located in the cytoplasm close to the cell surface.  There 
was no intracellular staining under these conditions (no per- 
meabilization). 
Stow and Fatquhar Heparan Sulfate  Proteoglycam in Cultured Cells  535 Figure 7. Distribution of basement membrane HSPGs in CHO cells reacted with anti-HSPG (GBM). The intercellular spaces between 
overlapping cells (C1 and C2) are filled with reactive extracellular matrix material, but no such material is seen on the free cell surfaces 
facing the medium (cm) or the substrate (cnf). Bars: (A) 0.5  ~tm; (B) 0.25  txm. 
In NRK cells there was a  similar distribution of staining 
with anti-HSPG (LM): reaction product was found along the 
entire surface of NRK cells, including vesicular profiles in 
continuity with the plasmalemma, but there was no staining 
of other  structures  (Fig.  9).  In  CHO  cells,  staining  with 
anti-HSPG (LM)  was  similarly distributed but was  some- 
what weaker than in the other cell types. 
Discussion 
Previously we have  identified two  different populations of 
Figure 8.  Localization of membrane HSPG in Clone 9 hepatocytes with anti-HSPG (LM). A continuous line of reaction product is dis- 
tributed in a continuous layer on the outer surface of the entire plasmalemma (cm) on both the upper cell surface facing the medium and 
the basal surface facing the plastic substrate (p). In B, microvilli  (my) present on the cell surface facing the medium are continuously outlined 
by reaction product. Bar, 0.25  Ixm. 
The Journal of Cell Biology,  Volume 105, 1987  536 Figure 9. Localization of membrane HSPG in NRK cells after immunoperoxidase staining with anti-HSPG (LM). Only the cell membrane 
(cm) and small vesicular profiles close to the cell surface (arrow) are stained, nu, nucleus; p, plastic substratum. Bar, 0.5 ~tm. 
HSPGs in rat tissues which can be distinguished by their char- 
acteristic distribution using specific antibodies. One type of 
HSPGs demonstrated by staining with anti-HSPG (GBM), 
was found to be associated with basement membranes in all 
tissues  surveyed which included kidney, liver, ovary, pan- 
creas,  pituitary,  and  intestine (7,  24,  37;  our unpublished 
observations).  The other type of HSPG,  demonstrated by 
staining  with  anti-HSPG (LM),  was  associated with  cell 
membranes. These HSPGs proved to be preferentially con- 
centrated on the basolateral  (vascular) plasmalemmal  do- 
main of hepatocytes (36) and kidney tubule cells (35).  In 
the present  study  we  have  obtained  immunocytochemical 
data demonstrating that cell lines in  culture also produce 
these two antigenically distinct populations of HSPG and that 
each of these populations has a characteristic and unique dis- 
tribution in the cell monolayers. The HSPGs recognized by 
anti-HSPG (LM), raised against liver membrane HSPG, are 
distributed in a continuous layer along the entire cell mem- 
brane, whereas those stained by anti-HSPG (GBM) which 
recognizes basement membrane HSPGs, are concentrated in 
clumps of poorly organized extracellular matrix material of 
varying sizes and shapes located in pockets of  the cell surface 
or in sites of cell-cell or cell-substrate attachment. By im- 
munofluorescence these latter HSPGs colocalized in extra- 
cellular deposits with fibronectin and laminin, but none of 
these extracellular matrix components was incorporated into 
a morphologically recognizable basement membrare layer. 
The main differences between the present findings in mono- 
layers of cultured cell lines and those obtained previously in 
situ  are as  follows:  (a)  the matrix-type HSPGs are much 
more irregularly distributed and are not incorporated into a 
regular, organized basement membrane; and (b there is no 
preferential concentration of membrane-type HSPG on any 
particular domain of the plasmalemma.  The latter observa- 
tion is not surprising because, in contrast to liver and kidney 
in situ, these cells are not polarized-i.e., they do not make 
occluding junctions  and  do not deposit a  basal  basement 
membrane layer. 
We also obtained corroborating biochemical evidence for 
the existence of at least two populations of HSPGs of varying 
hydrophobicity in the cell lines studied. When we isolated 
HSPGs (by chondroitinase ABC digestion of total proteogly- 
can fractions) and separated them on octyl-Sepharose col- 
umns,  40-50%  (depending  on the  cell  type) of the  total 
HSPGs bound to the column and was eluted with 1% Triton 
X-100, whereas the remainder did not bind. Those that bound 
to octyl-Sepharose are assumed to correspond to membrane- 
intercalated HSPGs, based on their hydrophobic properties 
(16, 25) and on previous studies on rat liver (15, 16) and cul- 
tured cells (4, 25). The other type of HSPGs failed to bind 
to octyl-Sepharose  and included basement membrane HSPGs, 
because •40-50%  of the total counts could be immunopre- 
cipitated with anti-HSPG (GBM) serum. This fraction must 
also contain one or more additional, antigenically distinct 
populations of HSPGs (e.g., membrane-intercalated HSPGs 
which have lost their hydrophobic membrane tails [15, 28]), 
since 50-60 % of the total was not recognized by anti-HSPG 
(GBM). 
HSPGs with different properties have been found in as- 
sociation with the media and cell layers of a variety of cells 
in culture (2, 4, 11, 15, 18, 21, 23, 25, 27, 32, 38). In relatively 
few cases have HSPG populations been studied using spe- 
cific antibodies (14, 23, 29, 38). Usually, they are character- 
ized solely based on differences in their physical properties 
(hydrodynamic size, buoyant density). Their nature (mem- 
brane-intercalated vs. matrix-associated) and distribution in 
the monolayer has been deduced based on their ease of ex- 
traction. For example, those released by heparin treatment 
are assumed to represent either matrix-type HSPGs or mem- 
brane HSPGs that have lost their hydrophobic tails (13, 15); 
those released by detergent or trypsin are assumed to consist 
of membrane-intercalated HSPGs  (40);  and  those not re- 
leased by any of these treatments are assumed to consist of 
HSPGs associated with intracellular compartments (41). Our 
immunocytochemicai results indicate that (a) both the mem- 
brane-type and the matrix- (basement membrane) type HSPC~ 
are closely associated with the cell surface, and (b) the distri- 
bution of the latter HSPG in the monolayer can vary con- 
siderably, being found in some cases on one cell surface and 
in others on all cell surfaces (i.e., that facing the medium as 
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can be expected to considerably complicate attempts to se- 
lectively extract either population of HSPG and to obtain 
purified populations of HSPGs for further analysis. 
It is of interest that although Clone 9 hepatocytes and NRK 
cells, like many other cell lines, do not normally produce an 
organized basement membrane, they nevertheless produce 
basement membrane components,  including  HSPGs.  Our 
immunofluorescence results  have demonstrated that these 
HSPGs have a distribution which is similar to that of fibro- 
nectin and laminin. This colocalization of extracellular ma- 
trix components was described previously in NRK cell cul- 
tures by immunofluorescence (11). It was assumed that these 
elements were assembled into a basement membrane-like 
matrix; however, our immunoelectron microscopic results 
demonstrate that in both NRK and Clone 9 cells they are not 
deposited in a typical basally located basement membrane. 
Rather they are assembled into packets or aggregates of ir- 
regular sizes and shapes which in three dimensions form an 
irregular reticulum found between or underneath the cells in 
the monolayers. The factors instrumental in the assembly of 
basement membrane components into an organized mem- 
brane layer are unknown at present but are worthy of further 
study. 
A  further finding  is  that  in  Clone  9  cells  matrix-type 
HSPGs are often localized in sites of cell-cell attachment as 
well as in adhesion plaques- i.e., points of contact between 
the basal cell membrane and the plastic dish which appar- 
ently  function  in  cell-substrate  attachment.  It  has  been 
known for some time that HSPGs are an important compo- 
nent of adhesion sites in fibroblasts (18, 32, 38). 
A well-known property of HSPGs is their ability to spe- 
cifically interact with both cell membrane constituents (16) 
and matrix components including type I collagen (17), lami- 
nin (34), and fibronectin (39), which possess specific bind- 
ing sites for heparan sulfate. One of the proposed functions 
of cell membrane HSPGs is that they form a link between 
the extracellular matrix, the cell surface, and the intracellu- 
lar cytoskeleton (4, 27, 38). 
At present it is not known how much homology or diver- 
sity exists between the protein cores of different populations 
of HSPG. It is clear from our studies (35-37) as well as those 
of others (14, 23) that there are antigenically distinct popula- 
tions  of basement  membrane-associated  and  membrane- 
associated HSPGs. Within these two families further diver- 
sity in GAG composition and core protein size has been 
described. For example, cell membrane HSPGs with both 
chondroitin and heparan sulfate side chains have been iso- 
lated from mammary cells (6, 30). Also, two forms of base- 
ment membrane HSPGs have been isolated from the Engle- 
breth-Holm swarm sarcoma (9,  10)-a large, low buoyant 
density HSPG and a smaller, high density HSPG-which are 
antigenically related. Ledbetter et al. (19) have identified a 
large precursor assumed to give rise by proteolysis to both 
the high and low density HSPG. A population of  large HSPGs 
immunologically related to those of the Englebreth-Holm 
swarm sarcoma has been identified in the extraceUular ma- 
trix produced by parietal yolk sac (PYS) cells in culture (26), 
and another large (750,000  mol wt) HSPG associated with 
basement membranes has also been isolated from L2 cell 
cultures (8). The relationship between the basement mem- 
brane HSPC~ produced by tumor cell lines and those pro- 
duced by normal cells in situ is not yet clear. 
Further work is required to determine to what extent these 
different populations of basement membrane HSPGs resem- 
ble or differ from one another and from membrane-asso- 
ciated HSPGs. The availability in the future of the amino 
acid sequences of the core proteins of cell surface and base- 
ment membrane populations of HSPGs derived from differ- 
ent sources will be required to resolve these issues. 
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